Maryland-based clinical-stage biotechnology company developing stabilized platelet-derived biologics for bleeding control and transfusion medicine
Maryland-based clinical-stage biotechnology company developing stabilized platelet-derived biologics for bleeding control and transfusion medicine. Its human pipeline includes frozen activated platelets and freeze-dried platelet-derived hemostatic products for settings such as trauma, surgery, and traumatic brain injury. Through veterinary subsidiary BodeVet, it also develops freeze-dried platelet and plasma products for companion and other animals.